Dyfyniad APA

Aoki, T., Arakawa, Y., Ueba, T., Oda, M., Nishida, N., Akiyama, Y., . . . Miyamoto, S. (2020). CTNI-32. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP. Neuro Oncol.

Dyfyniad Arddull Chicago

Aoki, Tomokazu, et al. "CTNI-32. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP." Neuro Oncol 2020.

Dyfyniad MLA

Aoki, Tomokazu, et al. "CTNI-32. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP." Neuro Oncol 2020.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.